DAFALGAN Dolo Junior siroup 150 ml

7680699040087 CH-69904 N02BE01 01.01.1.
DAFALGAN Dolo Junior siroup 150 ml
DAFALGAN Dolo Junior siroup 150 ml
DAFALGAN Dolo Junior siroup 150 ml
1 / 3
google

Details

Product number
6990401
CPT
-
Packaging group
150
Unit
ml
Composition
paracetamolum 30 mg, macrogolum 6000, glycerolum, saccharum 268 mg, saccharinum natricum corresp. natrium 0.17 mg, E 202, acidum citricum, aromatica (Erdbeer) cum propylenglycolum 3.54 mg, aqua purificata, ad solutionem pro 1 ml.

Articles (1)

Dafalgan Dolo Junior, Sirup
Sirup
150
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
01/08/2025
Patient information leaflet
Français
01/08/2025
Patient information leaflet
Italien
01/08/2025
Professional SmPC
Allemand
01/08/2025
Professional SmPC
Français
01/08/2025
Professional SmPC
Italien
01/08/2025

Detailed composition

Substance Quantity Type Category
(N/A)
30.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
268.0 MG Substance HBESI
(N/A)
- Substance HIMDK
(N/A)
0.17 MG Substance HBESI
(N/A)
- Substance Konservierungsstoff (Conservateur)
(N/A)
- Substance HNIDK
(N/A)
- Substance AROMA
(N/A)
3.54 MG Substance HBESI
(N/A)
- Substance HNIDK

Authorization holder

UPSA Switzerland AG

6300 Zug

Authorization information

Swissmedic authorization number
69904
Drug name
Dafalgan Dolo Junior, Sirup
Galenic form
SIRU
ATC Code
N02BE01
Authorization status
Z
Dispensation category
D
First authorization
06/08/2024
Authorization expiration date
31/12/9999
IT number
01.01.1.
Domain
Human medicine
Field of application
Analgetikum, Antipyretikum

Packaging details

Description (FR)
DAFALGAN Dolo Junior siroup 150 ml
Description (DE)
DAFALGAN Dolo Junior Sirup 150 ml
Market launch
07/07/2025
Narcotic (BTM)
No

Other packaging sizes